These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18208572)

  • 1. A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans.
    Madsen JL; Fuglsang S
    Aliment Pharmacol Ther; 2008 Apr; 27(7):609-15. PubMed ID: 18208572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
    Gan TJ; Apfel CC; Kovac A; Philip BK; Singla N; Minkowitz H; Habib AS; Knighton J; Carides AD; Zhang H; Horgan KJ; Evans JK; Lawson FC;
    Anesth Analg; 2007 May; 104(5):1082-9, tables of contents. PubMed ID: 17456656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sildenafil on gastric emptying and postprandial frequency of antral contractions in healthy humans.
    Madsen JL; Søndergaard SB; Fuglsang S; Rumessen JJ; Graff J
    Scand J Gastroenterol; 2004 Jul; 39(7):629-33. PubMed ID: 15370682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers.
    Majumdar AK; Howard L; Goldberg MR; Hickey L; Constanzer M; Rothenberg PL; Crumley TM; Panebianco D; Bradstreet TE; Bergman AJ; Waldman SA; Greenberg HE; Butler K; Knops A; De Lepeleire I; Michiels N; Petty KJ
    J Clin Pharmacol; 2006 Mar; 46(3):291-300. PubMed ID: 16490805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone.
    McCrea JB; Majumdar AK; Goldberg MR; Iwamoto M; Gargano C; Panebianco DL; Hesney M; Lines CR; Petty KJ; Deutsch PJ; Murphy MG; Gottesdiener KM; Goldwater DR; Blum RA
    Clin Pharmacol Ther; 2003 Jul; 74(1):17-24. PubMed ID: 12844131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
    Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
    Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of erythromycin on gastric emptying, duodeno-caecal transit time, gastric and biliopancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers.
    Landry C; Vidon N; Sogni P; Nepveux P; Chaumeil JC; Chauvin JP; Couturier D; Chaussade S
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):797-802. PubMed ID: 7496872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of palonosetron in combination with aprepitant in healthy volunteers.
    Shah AK; Hunt TL; Gallagher SC; Cullen MT
    Curr Med Res Opin; 2005 Apr; 21(4):595-601. PubMed ID: 15899109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral domperidone on gastric emptying and motility. A double-blind comparison with placebo and metoclopramide.
    De Schepper A; Wollaert F; Reyntjens A
    Arzneimittelforschung; 1978; 28(7):1196-9. PubMed ID: 582709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women.
    Gonenne J; Esfandyari T; Camilleri M; Burton DD; Stephens DA; Baxter KL; Zinsmeister AR; Bharucha AE
    Neurogastroenterol Motil; 2006 Oct; 18(10):911-8. PubMed ID: 16961694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans.
    Bouras EP; Burton DD; Camilleri M; Stephens DA; Thomforde GM
    Neurogastroenterol Motil; 2004 Dec; 16(6):729-35. PubMed ID: 15601422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the H2-receptor antagonist ranitidine on gastric motor function after a liquid meal in healthy humans.
    Madsen JL; Graff J
    Scand J Clin Lab Invest; 2008; 68(8):681-4. PubMed ID: 18609122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.
    Bharucha AE; Seide B; Guan Z; Andrews CN; Zinsmeister AR
    Neurogastroenterol Motil; 2008 Jun; 20(6):643-8. PubMed ID: 18312543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients.
    Loos WJ; de Wit R; Freedman SJ; Van Dyck K; Gambale JJ; Li S; Murphy GM; van Noort C; de Bruijn P; Verweij J
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):407-12. PubMed ID: 17051369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects.
    Lasseter KC; Gambale J; Jin B; Bergman A; Constanzer M; Dru J; Han TH; Majumdar A; Evans JK; Murphy MG
    J Clin Pharmacol; 2007 Jul; 47(7):834-40. PubMed ID: 17525168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a neurokinin-1 receptor antagonist (aprepitant) on gastric sensorimotor function in healthy volunteers.
    Ang D; Pauwels A; Akyuz F; Vos R; Tack J
    Neurogastroenterol Motil; 2013 Dec; 25(12):e830-8. PubMed ID: 23991829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.